SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-15-006068
Filing Date
2015-11-05
Accepted
2015-11-05 17:00:20
Documents
2
Period of Report
2015-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FILING DOCUMENT document.htm 8-K 6764
2 PRESS RELEASE newsrelease.htm EX-99 43729
  Complete submission text file 0001171843-15-006068.txt   51774
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 151201477
SIC: 2834 Pharmaceutical Preparations